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ttp://dx.doi.org/10.1016/j.ajpath.2013.08.017Periodontal disease is the most common osteolytic disease in humans and is signiﬁcantly increased by
diabetes mellitus. We tested the hypothesis that bacterial infection induces bone loss in diabetic
animals through a mechanism that involves enhanced apoptosis. Type II diabetic rats were inoculated
with Aggregatibacter actinomycetemcomitans and treated with a caspase-3 inhibitor, ZDEVD-FMK, or
vehicle alone. Apoptotic cells were measured with TUNEL; osteoblasts and bone area were measured in
H&E sections. New bone formation was assessed by labeling with ﬂuorescent dyes and by osteocalcin
mRNA levels. Osteoclast number, eroded bone surface, and new bone formation were measured by
tartrate-resistant acid phosphatase staining. Immunohistochemistry was performed with an antibody
against tumor necrosis factor-a. Bacterial infection doubled the number of tumor necrosis factor-ae
expressing cells and increased apoptotic cells adjacent to bone 10-fold (P < 0.05). Treatment with
caspase inhibitor blocked apoptosis, increased the number of osteoclasts, and eroded bone surface (P <
0.05); yet, inhibition of apoptosis resulted in signiﬁcantly greater net bone area because of an increase
in new bone formation, osteoblast numbers, and an increase in bone coupling. Thus, bacterial infection
in diabetic rats stimulates periodontitis, in part through enhanced apoptosis of osteoblastic cells
that reduces osseous coupling through a caspase-3edependent mechanism. (Am J Pathol 2013, 183:
1928e1935; http://dx.doi.org/10.1016/j.ajpath.2013.08.017)Supported by NIH grant DE017732 (D.T.G.). B.B.B. was the recipient of
a scholarship from the Coordination for the Improvement of Higher Edu-
cation Personnel (CAPES) Foundation in Brazil. Dynamic bone labeling
analysis was supported in part by the Penn Center for Musculoskeletal
Disorders P30AR050950 from NIAMS.Diabetes is a chronic inﬂammatory disease characterized by
hyperglycemia that affects 26 million Americans.1 Diabetes
has several complications, such as cardiovascular, renal,
microvascular, and periodontal diseases. Periodontal disease
is one of the most common forms of osteolytic bone disease
and one of the most frequent complications of the diabetes.2
Recent research suggests that the relationship between
periodontitis and diabetes is reciprocal.3,4 People with dia-
betes are more susceptible to periodontitis, and periodontitis
may affect serum glucose levels and contribute to progres-
sion of diabetes.5 Diabetes may contribute to periodontitis
because of its effect on inﬂammation.6,7 Despite being
triggered by bacterial infection, periodontal bone loss is tied
to the inﬂammatory host response, which leads to the gen-
eration of prostaglandins and cytokines that stimulate
osteoclastogenesis and periodontal bone loss.8stigative Pathology.
.Several of the detrimental aspects of periodontal disease
have recently been shown to be mediated by elevated levels
of tumor necrosis factor-a (TNF-a).9,10 TNF-a is a proin-
ﬂammatory cytokine produced by leukocytes and other cell
types.11 Enhanced TNF-a levels have been directly linked
to cellular changes in diabetic retinopathy, deﬁcits in
wound healing, and diabetes-enhanced periodontitis.12e14
Some of the detrimental effects of diabetes-enhanced
TNF-a levels may be because of the induction of cell
death by triggering caspase activity. Caspases are a family
Apoptosis and Bone Lossof cysteine proteases that can act as either initiators (cas-
pases 2, 8, and 9) or executioners (caspases 3, 6, and 7) of
apoptosis.15 Caspase-3 appears to play a central role in
bacteria and lipopolysaccharide-mediated apoptosis.16,17 In
addition, it has been shown that TNF-a can stimulate the
expression of several pro-apoptotic genes, many of which
are regulated by the pro-apoptotic transcription factor,
forkhead box-O1 (FOXO1).18
The functional role of apoptosis in pathological pro-
cesses can be studied with caspase inhibitors, which are
small peptides that block the activity of well-deﬁned cas-
pases.19 These inhibitors have been used in animal models
to attenuate cell death and diminish tissue damage in
ischemic conditions, sepsis, and other pathological pro-
cesses.20,21 Other studies using caspase inhibitors have
shown that part of the detrimental effect of diabetes on
healing after infection is the result of increased ﬁbroblast
or osteoblast apoptosis.16,22 To understand how diabetes
may affect periodontal bone loss through apoptosis, we
used a caspase-3/7 inhibitor in a type 2 Goto-KakizakiThe American Journal of Pathology - ajp.amjpathol.org(GK) diabetic rat model of periodontal disease induced
by bacterial infection. The aim of this study was to
determine how apoptosis of osteoblasts contributed to
periodontal bone loss by its effect on bone formation in
diabetic animals.
Materials and Methods
Animals
GK male and female rats were purchased from Charles
River Laboratories (Wilmington, MA). The GK rat naturally
develops type 2 diabetes mellitus at the age of approxi-
mately 12 weeks. Rats were housed in separate cages and
fed powdered food (Laboratory Rodent Meal Diet 5001;
Purina Mills Feeds, St. Louis, MO). When glucose levels
were >220 mg/dL, and glycated hemoglobin levels were
>7.0%, they were classiﬁed as diabetic. All animal pro-
cedures were approved by the Institutional Animal Care and
Use Committee.Figure 1 Diabetes increases apoptosis in
bacteria-infected rats. Destructive periodontitis
was initiated in GK diabetic rats by oral inocula-
tion with the periodontal pathogen, A. actino-
mycetemcomitans, once daily for 4 consecutive
days per week for 2 weeks. Four weeks after bac-
terial inoculation was completed, rats were treated
with antibiotic to halt the infection. Caspase-3
was inhibited by injection with Z-DEVD-FMK daily
1 week before euthanasia. Control rats received
vehicle alone. Rats were euthanized before the
inoculation of the bacteria (baseline) and 5 or 6
weeks after inoculation was completed. AeC:
TUNELþ cells close to bone are indicated by ar-
rows. The dotted lines demark the different tissue
in the histologic section, bone, connective tissue
(CT) and tooth. D and E: The number of TUNELþ
cells in the periodontal ligament close to bone and
bone-lining cells was examined. F and G: The
number of TUNELþ/CD18 cells in the periodontal
ligament close to bone and bone-lining cells was
examined. PDL, periodontal ligament; TX, treat-
ment. *P < 0.05, a statistically signiﬁcant dif-
ference between the AB and AB þ Inh; yP < 0.05,
a signiﬁcant difference compared with baseline.
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Pacios et alDiabetic (GK) rats received antibiotics ad libitum in their
drinking water for 4 days (20 mg kanamycin and 20 mg
ampicillin) and were swabbed with a 0.12% chlorhexidine
gluconate rinse during the past 2 days (Procter and Gamble,
Cincinnati, OH) to facilitate colonization by Aggregatibacter
actinomycetemcomitans. After 3 days without antibiotic treat-
ment and fasting for 3 hours, 109 A. actinomycetemcomitans
cells [adherent A. a strain; A. actinomycetemcomitans clinical
isolate 1000 (CU1000NRif); Columbia University, New
York, NY] were administered by oral gavage to diabetic
(GK) rats, and 109 A. actinomycetemcomitans cells was also
placed in their food once a day for 8 days, as previously
described.23 Some groups received antibiotic or antibiotic
plus caspase-3 inhibitor starting 4 weeks after the feeding
regimen. Antibiotic treatment, as previously described,
continued for 4 days to arrest A. actinomycetemcomitans
infection.23 These animals were euthanized 1 and 2 weeks
after the start of the antibacterial regimen (5 and 6 weeks
after A. actinomycetemcomitans inoculation, respectively).
Caspase-3 inhibitor, ZDEVD-FMK (SM Biochemicals,
Anaheim, CA), was administered daily by 1.5 mg/kg i.p.
injection starting at 4 weeks and rats were euthanized 1 or 2
weeks later. Animals not treated with caspase inhibitor were
injected i.p. with the same volume of vehicle, 2% dimethyl
sulfoxide (MP Biomedicals, Solon, OH).Analysis of TNF-a and Apoptosis in Histological
Sections
Immunohistochemistry was performed with an antibody
against TNF-a (IHCWORLD, Woodstock, MD). The number
of immunopositive cells adjacent to bone was evaluated, as weFigure 2 The loss of osteoblasts caused by periodontal disease in diabetic ani
diabetic rats treated with antibiotic or antibiotic plus caspase-3 inhibitor, as des
indicated by arrows and dotted lines. H: The number of osteoblasts was measure
treatment. *P < 0.05, a statistically signiﬁcant difference between the AB and A
1930have previously described,13 at600magniﬁcation. Apoptotic
cells were detected by TUNEL assay (DeadEnd Fluorometric
TUNEL System kit; Promega, Madison, WI). Apoptosis was
measured simultaneously with immunoﬂuorescence with an
anti-CD18 antibody (Novus Biological, Littleton, CO) to avoid
counting apoptotic leukocytes. The number of nonleukocytic
apoptotic cells (TUNELþCD18) was counted at 200
magniﬁcation with an immunoﬂuorescence microscope using
NIS Elements software version 4.2 (Nikon, Melville, NY) in a
region adjacent to bone and in bone-lining cells. Experiments
were performed with six to seven animals per group.Osteoblasts, Osteoclasts, Eroded Bone, New Bone
Formation, and Bone Coupling
Osteoblasts were counted as cuboidal bone-lining cells in areas
of bone remodeling in H&E-stained sections. Osteoclasts,
eroded bone, and new bone formation were measured with
tartrate-resistant acid phosphatase (TRAP)estained sec-
tions, as previously described.13 Bone mineral apposition
was also measured by using calcein blue (Sigma-Aldrich,
St. Louis, MO) and alizarin red (Sigma-Aldrich) ﬂuorescent
staining. Calcein blue was given by i.p. injection at 4 weeks,
and alizarin red was given 24 hours before euthanasia.
Metabolic labeling of new bone formation was measured by
ﬂuorescence microscopy in methacrylate-embedded sec-
tions. The area between the two ﬂuorescent labels was
analyzed.24 Bone coupling was calculated as the newly
formed bone area/the number of osteoclasts or the per-
centage of eroded bone. Bone area was measured as the
percentage area occupied by bone. Experiments were per-
formed with six to seven animals per group.mals is reversed by inhibition of caspase-3. Periodontitis was induced in GK
cribed in Figure 1. AeG: H&E-stained histological images. Osteoblasts are
d per mm bone length at 5 and at 6 weeks after inoculation of bacteria. TX,
B þ Inh; yP < 0.05, a signiﬁcant difference compared with baseline.
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Figure 3 Bacteria-induced periodontal bone loss is reduced by inhi-
bition of apoptosis in diabetic rats. Periodontitis was induced in GK dia-
betic rats treated with antibiotic or antibiotic plus caspase-3 inhibitor, as
described in Figure 1. AeC: H&E-stained histological sections. D: Bone area
was calculated as the percentage area occupied by bone. TX, treatment. *P
< 0.05, a statistically signiﬁcant difference between the AB and AB þ Inh;
yP < 0.05, a signiﬁcant difference compared with baseline.
Figure 4 Inhibition of apoptosis increases new bone formation and
enhances osteocalcin mRNA levels. Periodontitis was induced in GK diabetic
rats treated with antibiotic or antibiotic plus caspase-3 inhibitor, as
described in Figure 1. A and B: TRAP-stained histological sections. Black
arrows indicate the reversal line; white arrows and dotted lines, the
extent of new bone formation. C: New bone formation was assessed per
mm2 bone length. D: Osteocalcin mRNA levels were measured in total RNA
obtained from the rat periodontium by real-time PCR. CT, connective tissue;
TX, treatment. *P < 0.05, **P < 0.01, a statistically signiﬁcant difference
between the AB and AB þ Inh; yP < 0.05, a signiﬁcant difference compared
with diabetic baseline.
Apoptosis and Bone LossReal-Time PCR
Total RNA was extracted from the periodontium of the sec-
ond and third molars, as previously described.13 mRNA
levels of osteocalcin were assessed by real-time PCR using
TaqMan primers and probe sets for osteocalcin (Applied
Biosystems, Foster City, CA). Results were normalized to a
housekeeping gene, ribosomal protein L32. The experiments
were performed with six to seven animals per group, with
triplicate samples, and performed twice, with similar results.
Statistical Analysis
Statistical analyses were performed using SPSS software
version 20 (SPSS, Chicago, IL). One-way analysis of vari-
ance with contrast analysis was used to compare the dif-
ferences between groups at a given time point and to
compare differences from baseline values with the other
time points. The signiﬁcance level was set at P < 0.05.
Results
Apoptosis was measured as the total number of apoptotic
cells (TUNELþ) and the number of nonleukocytic apoptotic
cells (TUNELþ/CD18) per mm2 in the periodontal liga-
ment adjacent to bone and lining the bone surface. AtThe American Journal of Pathology - ajp.amjpathol.orgbaseline, the number of apoptotic cells was low. Five weeks
after A. actinomycetemcomitans infection, the level of
apoptosis increased by approximately 90% in cells adjacent
to bone and lining the bone surface (P < 0.05). The increase
in apoptosis with infection can be accounted for by a sig-
niﬁcant increase in expression of pro-apoptotic factors, such
as TNF-a, in close proximity to bone. At baseline, the
percentage TNF-aepositive cells was 11% and more than1931
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Figure 5 Periodontal bone formation is increased by caspase 3-inhibitor.
Periodontitis was induced in GK diabetic rats, which were treated with anti-
biotic or antibiotic plus caspase-3 inhibitor, as described in Figure 1. A and B:
New bone formation was measured using ﬂuorescent staining in methacrylate-
embedded sections. The distance between ﬂuorescent labels (white arrows)
was used to assess new bone formation. The dotted line represents the
boundary between bone and periodontal ligament; solid line, boundary be-
tween periodontal ligament and tooth. C: New bone formation was assessed at
5- and 6-week time points. *P < 0.05, a statistically signiﬁcant difference
between the AB and AB þ Inh; yP < 0.05, a signiﬁcant difference compared
with the 5 weeks no treatment (TX) group.
Pacios et aldoubled to 25% at 5 weeks (P < 0.05). Treatment with
antibiotic and caspase-3 inhibitor (AB þ Inh) reduced
apoptosis to near-baseline levels (Figure 1, AeE). The same
pattern was shown with the number of TUNELþ/CD18
cells (Figure 1, F and G). In comparison, antibiotic treat-
ment alone (AB) had only a small effect on these values.
Bone resorption is followed by bone formation in a process
referred to as coupling.25 In periodontal disease and other bone
pathological conditions, bone coupling is decreased.10 We
evaluated whether inhibition of apoptosis altered the number
of osteoblasts present (Figure 2). Osteoblast numbers
decreased after induction of periodontal disease (Figure 2H),
consistent with an increase in apoptosis (P < 0.05). Halting
periodontitis with the administration of antibiotics increased
the number of osteoblasts by 50% (P < 0.05). However,
treatment with caspase-3 inhibitor increased the number even
further, by 68% at 5 weeks and 64% at 6 weeks, compared
with the same time point without antibiotic or inhibitor (P <
0.05). Thus, much of the increase in osteoblast numbers could
be directly tied to reduced apoptosis from treatment with the
caspase-3 inhibitor. Furthermore, bone area increased 50%
with caspase-3 inhibitor treatment (P < 0.05) (Figure 3).
To measure the impact of caspase-3 inhibitor on bone, new
bone formation was measured with different approaches.
First, parafﬁn sections with TRAP staining, which used the
reversal line as a guide (Figure 4, A and B), showed that the
level of new bone formation increased 45%when diabetic rats
were treated with caspase-3 inhibitor (P< 0.05) (Figure 4C).
Treatment with the antibiotic alone had no discernible change
in bone formation. Second, the amount of newbone formation
was measured at the RNA level by expression of osteocalcin
mRNA (Figure 4D). Diabetic rats had low osteocalcinmRNA
levels at 5 weeks. When diabetic rats were treated with anti-
biotic þ inhibitor, there was a 63% increase compared with
the baseline (P < 0.05). Antibiotic alone did not show any
effects. Third, new bone formation was assessed using ﬂuo-
rescent staining inmethacrylate-embedded sections (Figure 5,
A and B). The administration of caspase inhibitor increased
the amount of new bone formation by 80% at 5 weeks and
60% at 6 weeks, compared with the antibiotic-treated group at
the same time point (P < 0.05) (Figure 5C). Antibiotic alone
had little effect on the amount of bone formed.
To analyze the effect of caspase-3 inhibitor treatment on
bone resorption, the number of osteoclasts (Figure 6, AeC)
and the percentage eroded bone surface that measures
osteoclast activity were assessed. Osteoclast numbers and
osteoclast activity increased by approximately 70% after the
infection (Figure 6, D and E). Antibiotic alone did not show
any signiﬁcant increase compared with the 5-week time
point with no treatment, but the treatment with caspase in-
hibitor increased the number of osteoclasts by 45% and
eroded bone surface by 80% (P < 0.05).
To assess the impact of diabetes on bone coupling, the
amount of new bone formation determined by metabolic
labeling was divided by an assessment of osteoclast
numbers or eroded bone surface (Figure 7). Treatment with1932antibiotics alone did not increase in bone coupling. Treat-
ment with caspase-3 inhibitor signiﬁcantly increased bone
coupling by approximately 40% when measured relative to
osteoclast numbers (Figure 7A) or by 41% when examined
per eroded bone surface (Figure 7B) (P < 0.05).
Discussion
We previously reported that diabetes signiﬁcantly enhanced
inﬂammation in the periodontium and that the diabetes-
enhanced inﬂammation was tied to high levels of apoptosis in
the epithelium and connective tissue of diabetic animals.13,26
In the present study, we functionally examined the role of
high levels of apoptosis in diabetic animals to determine its
contribution to periodontal bone loss, examining parameters
of bone formation and bone resorption to assess bone
coupling. We examined a 5- to 6-week time period, which is
7 to 8 weeks after periodontal infection was initiated, to allow
sufﬁcient time for bone resorption to occur and subsequent
bone coupling after infection was treated.27,28 The results
indicate that blocking apoptosis signiﬁcantly increases the
number of bone-lining and periodontal ligament cells capable
of forming osteoblasts. This ultimately affected osteoblast
numbers, which were signiﬁcantly increased when caspase-
3emediated apoptosis was inhibited. The caspase-3e
speciﬁc inhibitor also increased signiﬁcantly the amount of
new bone formed by assessing parafﬁn sections, methacry-
late sections from metabolically labeled bone specimens, and
mRNA levels of the bone matrix protein, osteocalcin.
Furthermore, the number of osteoclasts and their activity
were increased by the caspase-3 inhibitor. However, the net
effect was an increase in bone area because of enhanced boneajp.amjpathol.org - The American Journal of Pathology
Figure 6 Osteoclast numbers and activity are
increased by caspase-3 inhibitor. Periodontitis was
induced in GK diabetic rats, which were treated
with antibiotic or antibiotic plus caspase-3 inhib-
itor, as described in Figure 1. AeC: TRAP-stained
histological images. The arrows indicate osteo-
clasts. D and E: Quantitative assessment of oste-
oclast numbers and the eroded bone surface per
total bone surface. CT, connective tissue; TX,
treatment. *P < 0.05, a statistically signiﬁcant
difference between the AB and AB þ Inh; yP <
0.05, a signiﬁcant difference compared with
baseline.
Figure 7 Bone coupling is increased by the administration of the
caspase-3 inhibitor. Periodontitis was induced in GK diabetic rats, which
were treated with antibiotic or antibiotic plus caspase-3 inhibitor, as
described in Figure 1. A: Bone coupling assessed by new bone formation (see
Figure 5)/osteoclast numbers. B: Bone coupling assessed by new bone for-
mation/eroded bone surface. *P< 0.05, a statistically signiﬁcant difference
compared with AB and compared with diabetic no treatment (TX).
Apoptosis and Bone Losscoupling, indicating that bacterial infection in diabetic ani-
mals during the period of bone formation has a signiﬁcant
impact on periodontal disease through enhanced apoptosis of
osteoblasts that form bone or their precursors. This is the ﬁrst
demonstration, to our knowledge, that shows that apoptosis
signiﬁcantly contributes to periodontal bone loss in bacteria-
induced periodontitis.
Other diabetic complications have been associated with
enhanced levels of apoptosis. For instance, diabetic neuropa-
thy and diabetes-enhanced cardiovascular disease are signiﬁ-
cantly affected by apoptosis of neuronal cells and myocardial
cells, respectively.29,30 The inhibition of apoptosis through
caspase-3 has been linked to reduce pathological characteris-
tics. For example, a recent in vitro study showed blocking
caspase-3 partly blocked tight-junction protein degradation
that leads to stroke.31 Another in vivo study, in mice with a
reovirus central nervous system infection, showed that mice
lacking the caspase-3 gene were associated with a reduction in
severity of central nervous system tissue injury.32
Diabetes leads to the up-regulation of pro-apoptotic fac-
tors, including the formation of reactive oxidative species,
TNF-a, and advanced glycation end products.3,18 Each may
contribute to apoptosis. In addition, expression of several
genes affecting propagation of intracellular pro-apoptotic
signals or decreased expression of anti-apoptotic intracel-
lular signals and effectors is enhanced by diabetes.14,16 The
balance between pro-apoptotic and anti-apoptotic extracel-
lular and intracellular signals of these factors may be
inﬂuenced by members of the forkhead transcriptions fac-
tors, such as FOXO. FOXO plays a pivotal role in cell cycle
differentiation and apoptosis and may be a factor to over-
come NF-kBeassociated anti-apoptosis.18,33 In periodontal
disease, much of the pro-apoptotic effect of infection hasThe American Journal of Pathology - ajp.amjpathol.orgbeen linked to the host response.10,34 In vivo studies have
demonstrated that the inhibition of TNF-a reduces apoptosis
of connective tissue and bone-lining cells.13,35 Bacteria or
their components, such as lipopolysaccharide, stimulate1933
Pacios et alapoptosis through a TNF-dependent mechanism.17,35 We
demonstrated herein that TNF-a expression was up-regulated
in close proximity to bone after bacterial infection. However,
bacterial toxins from A. actinomycetemcomitans or other
bacteria may also enhance apoptosis, although this has
not been demonstrated in in vivo studies of periodontal
disease.36,37
We have previously shown that inﬂammation stimulated
by periodontal pathogens induces apoptosis of ﬁbroblasts or
osteoblasts through enhanced TNF-a levels.35,38 The host
response to periodontal pathogens in vivo has previously
been shown to stimulate apoptosis of bone cells through
activation of caspase-3.39 Inhibition of caspase-3 protects
bone-lining cells from inﬂammation- and oxidative
stresseinduced apoptosis in vivo.40 Our results demonstrate
that by inhibiting caspase-3, apoptosis of bone-lining cells
and their precursors is diminished and that the diminished
cell death plays a signiﬁcant role in preventing periodontal
bone loss in diabetic animals. Thus, apoptosis of osteoblasts
or their precursors is a limiting factor in bone coupling.
In contrast to osteoblasts, inﬂammatory mediators enhance
osteoclast lifespan by decreasing caspase-3 activation. For
example, IL-1a reduces osteoclast apoptosis by inhibiting
caspase-3 activity in vitro.41 Caspase-3 inhibitors suppress
osteoclast apoptosis in vitro.41,42 These ﬁndings agree with
our results, in which the number of osteoclasts and their ac-
tivity were increased when caspase-3 is inhibited. However,
there is a greater increase in bone formation than resorption
so that the net effect of inhibiting apoptosis in diabetic ani-
mals is to enhance bone formation. This is consistent with
other pathological conditions in which inﬂammation and
osteoblast apoptosis, through the caspase-3 pathway, have
been shown to contribute to reduced bone formation and
decreased bone mass in rheumatoid arthritis, ankylosing
spondylitis, and inﬂammatory bowel disease.43,44
We administered antibiotics to prevent persistent infec-
tion based on studies in which administration of antibiotics
causes a cessation of periodontitis.45 In our study, antibiotic
treatment helped improve some parameters, such as
increasing the number of osteoblasts; however, in general,
the effect of antibiotic alone was relatively small compared
with the addition of the caspase inhibitor.
In summary, diabetes has been shown to have a negative
effect on bone in periodontitis and on dental implants.42 We
demonstrate herein that diabetes has an important effect on
bone through apoptosis of bone-lining cells. These data,
combined with previous experimental results, indicate that
diabetes-enhanced inﬂammation causes accelerated loss of
osteoblasts and, thereby, reduces bone coupling. In the
absence of robust osseous coupling, there is loss of periodontal
bone, which is one of the characteristic manifestations of
periodontitis. This provides new insight as to how diabetes can
affect bone and may contribute to diabetes-enhanced peri-
odontitis and other pathological conditions in which diabetes
has a negative impact on bone, including osteoporosis and
impaired fracture healing.46 We have recently shown that1934diabetes-enhanced TNF-a plays a signiﬁcant role in the reso-
lution of periodontal inﬂammation and deﬁcient bone forma-
tion.13,47 These studies, along with results presented herein,
indicate that diabetes-enhanced periodontitis is signiﬁcantly
affected by elevated levels of inﬂammation and apoptosis.
Future studies may investigate mechanisms by which diabetes
leads to enhanced TNF-a levels, which may be helpful in
improving diabetes-impaired bone coupling.
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